CPT code 64575 denotes the open surgical implantation of a peripheral nerve neurostimulator electrode array used to treat chronic pain when sacral nerves are not involved. This code captures a targeted neuromodulation approach distinct from percutaneous lead placement and is relevant to surgical and pain-management practices nationwide. Its use affects facility and professional billing across inpatient and outpatient surgical settings and has implications for coverage, prior authorization, and quality measurement related to chronic pain interventions.

Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of how the code is defined clinically, common billing considerations, and the typical sites of service where the procedure is performed. The publication summarizes benchmarking points, payer coverage patterns where available, and recent policy or coding guidance that can influence claim adjudication. Clinical context clarifies the role of open peripheral nerve neurostimulator implantation within the broader landscape of neuromodulation for chronic pain.

This national-level summary is intended for billing managers, surgical and pain clinicians, and policy analysts seeking a clear description of the code, its clinical application, and the payer landscape relevant to CPT code 64575.